Edwards Lifesciences
EW
#495
Rank
$43.30 B
Marketcap
$73.83
Share price
-0.20%
Change (1 day)
-16.90%
Change (1 year)
Categories

P/E ratio for Edwards Lifesciences (EW)

P/E ratio as of June 2025 (TTM): 10.5

According to Edwards Lifesciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.4971. At the end of 2024 the company had a P/E ratio of 10.6.

P/E ratio history for Edwards Lifesciences from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202410.6-67.87%
202333.08.39%
202230.5-43.11%
202153.5-22.74%
202069.349.1%
201946.54.37%
201844.516.54%
201738.28.87%
201635.11.98%
201534.4106.95%
201416.6-11.75%
201318.8-46.71%
201235.43.53%
201134.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Boston Scientific
BSX
73.6 601.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
44.1 320.51%๐Ÿ‡บ๐Ÿ‡ธ USA
LeMaitre Vascular
LMAT
40.4 284.55%๐Ÿ‡บ๐Ÿ‡ธ USA
CryoLife
CRY
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
26.1 148.25%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ICU Medical
ICUI
-33.3-417.46%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.